Cite

HARVARD Citation

    Kaushik, D. et al. (2020). BBIQ, a pure TLR7 agonist, is an effective influenza vaccine adjuvant. Human vaccines & immunotherapeutics. 16 (8), pp. 1989-1996. [Online]. 
  
Back to record